rawfin.tv
Merck Acquires Terns for $6.7 Billion; Quant Analysis Highlights Top Pharma Stocks
MarketsstocksAI Generated

Merck Acquires Terns for $6.7 Billion; Quant Analysis Highlights Top Pharma Stocks

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Merck has completed a $6.7 billion acquisition of Terns, signaling significant M&A activity in the pharmaceutical sector. Concurrently, quantitative analysis has identified Indivior, Liquidia, and Crinetics as leading pharma companies.

MRKPharmaceuticalsM&AQuantitative AnalysisBiotech

Related Articles

Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

stocks
Ambarella Gains as Nvidia Emerges as Potential Third Bidder

Ambarella Gains as Nvidia Emerges as Potential Third Bidder

stocks
SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

stocks
Elon Musk Explores Merger Between SpaceX and Tesla

Elon Musk Explores Merger Between SpaceX and Tesla

stocks